Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PPHvsHRTSETF Comparison

ETF 1
PPH

VanEck Pharmaceutical ETF

This fund is part of
Uncategorized Equities
-0.5%
VS
ETF 2
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
+0.57%

VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.99% for HRTS. PPH is up 8.05% year-to-date (YTD) with -$377M in YTD flows. HRTS performs worse with 3.15% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of PPH and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PPH vs HRTS performance and flow charts

Performance

0.02.04.06.08.0%Jun 23Jun 30Jul 8Jul 15Jul 22

Cumulative Flows

-20 M0 M20 M40 MJun 23Jun 30Jul 8Jul 15Jul 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/23/2026
1M3MYTD1Y3Y5Y
Perf.
PPH
HRTS
+4.91%+4.86%
+9.10%+7.88%
+8.05%+3.15%
+25.56%+26.57%
+44.57%n/a
+62.95%n/a
Flows
PPH
HRTS
+$42M-$1M
-$106M-$70K
-$377M-$2M
+$252M-$6M
+$353M-
+$396M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PPH
HRTS
+20.72%+18.10%
+18.26%+16.06%
+15.76%n/a
+15.33%n/a
Max drawdown
PPH
HRTS
-4.39%-4.69%
-10.78%-10.68%
-17.98%n/a
-20.19%n/a
Max drawdown duration
PPH
HRTS
16d16d
122d170d
434dn/a
484dn/a
Trading data

Create an account to view trading data

Join for free
PPH
HRTS
Last sale
7/24/2026 at 1:30 PM
$110.62
$36.55
Previous close
07/23/2026
$109.95
$36.40
Consolidated volume
07/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PPH
HRTS
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
PPH
HRTS
Last price
$110.62
$36.55
1D performance
+0.61%
+0.43%
AuM$954.80 M$54.30 M
E/R0.36%0.99%
Characteristics
PPH
HRTS
Management strategyPassiveActive
ProviderVanEckTema
BenchmarkMVIS US Listed Pharmaceutical 25 Index-
N° of holdings2543
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011November 21, 2023
ESGNoNo
Advertisement
Exposure

Countries

PPH
USA
61.03%
United Kingdom
11.84%
Switzerland
10.63%
Other
16.49%
HRTS
USA
76.55%
Switzerland
7.26%
Other
16.19%

Sectors

PPH
Healthcare
100%
HRTS
Healthcare
99.57%
Other
0.43%
Advertisement

Diversification

PPH

Total weight of top 15 holdings out of 15

90.85%
HRTS

Total weight of top 15 holdings out of 15

64.29%

Top 15 holdings

Data as of June 30, 2026
PPH
Eli Lilly & Co.
20.64%
Novartis AG
10.63%
Merck & Co., Inc.
9.86%
Novo Nordisk A/S
5.38%
AbbVie, Inc.
4.60%
Pfizer Inc.
4.54%
Bristol Myers Squibb Co.
4.52%
GSK Plc
4.43%
Johnson & Johnson
4.41%
AstraZeneca PLC
4.34%
McKesson Corp.
4.06%
Sanofi
4.06%
Cencora, Inc.
3.32%
Haleon Plc
3.08%
Teva Pharmaceutical Industries Ltd.
2.99%
HRTS
Eli Lilly & Co.
11.91%
UnitedHealth Group, Inc.
5.58%
Novo Nordisk A/S
5.25%
Merck & Co., Inc.
4.11%
Roche Holding AG
3.96%
Thermo Fisher Scientific, Inc.
3.91%
AstraZeneca PLC
3.85%
Johnson & Johnson
3.84%
Revolution Medicines, Inc.
3.64%
Cytokinetics, Inc.
3.40%
Novartis AG
3.30%
Gilead Sciences, Inc.
3.09%
Vertex Pharmaceuticals, Inc.
3.04%
Abbott Laboratories
2.71%
Danaher Corp.
2.70%
Frequently asked questions about PPH and HRTS

How have the PPH and HRTS ETFs performed in 2026?

As of July 23, 2026, PPH is up 8.05% year-to-date (YTD), while HRTS has returned 3.15%. That puts PPH better performer ahead so far this year.

Which ETF is attracting more investor money: PPH or HRTS?

Year-to-date, the PPH ETF saw -$377M in flows, compared to -$2M for HRTS.

Which ETF is more volatile: PPH or HRTS?

Over the past year, PPH had a volatility of 18.26%, while HRTS experienced 16.06%.

Which ETF is bigger: PPH or HRTS?

As of July 23, 2026, PPH holds $954.80 M in assets under management (AUM), while HRTS manages $54.30 M.

What sectors do the PPH and HRTS ETFs invest in?

PPH leans toward sectors like Healthcare. Meanwhile, HRTS focuses on Healthcare.

What are the top holdings of the PPH ETF and HRTS ETF?

PPH top holdings include Eli Lilly & Co., Novartis AG and Merck & Co., Inc.. HRTS holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Novo Nordisk A/S.

Which ETF is more diversified: PPH or HRTS?

PPH holds 25 securities with 90.85% of its assets in the top 15. HRTS has 43 securities and a top 15 weight of 64.29%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder